GSK Exercises Option to License Chemo...

GSK Exercises Option to License ChemoCentryx's CCR1 Inhibitor,...

There are 1 comment on the Sys-Con Media story from Jan 5, 2012, titled GSK Exercises Option to License ChemoCentryx's CCR1 Inhibitor,.... In it, Sys-Con Media reports that:

"This announcement is a key milestone for ChemoCentryx that further validates our ability to advance new medicines from drug discovery through clinical development," said , Ph.D., President and Chief Executive Officer of ChemoCentryx.A "Furthermore, the exercise fee associated with this agreement provides additional financial flexibility to our ... (more)

Join the discussion below, or Read more at Sys-Con Media.


Toronto, Canada

#1 May 6, 2012

Tell me when this thread is updated:

Subscribe Now Add to my Tracker

Add your comments below

Characters left: 4000

Please note by submitting this form you acknowledge that you have read the Terms of Service and the comment you are posting is in compliance with such terms. Be polite. Inappropriate posts may be removed by the moderator. Send us your feedback.

Arthritis Discussions

Title Updated Last By Comments
News When You Should (And Shouldn't) See A Chiropractor (Dec '14) Oct 2 Callista Elizabet... 14
News How to File A Complaint About DIRECTV (Jul '08) Sep 19 CalCusttomer 236
News Advances Against Chronic Pain (Sep '12) Aug '15 Ambct617 20
News Total Knee Replacement: the First Year (Dec '14) Jul '15 huthnance 3
News Patients grapple with high cost of arthritis me... Jul '15 Walnut Fruitcake 2
News Nine of nature's most powerful traditional mult... (May '13) Jun '15 Mary Wilcoxon 6
Bee Venom Ointment for Arthritis Jun '15 Julio 1
More from around the web